Pamela Vig - Jan 8, 2024 Form 4 Insider Report for Mirum Pharmaceuticals, Inc. (MIRM)

Role
HEAD OF RESEARCH & DEVELOPMENT
Signature
/s/ Judit Ryvkin, Attorney-in-Fact
Stock symbol
MIRM
Transactions as of
Jan 8, 2024
Transactions value $
-$39,472
Form type
4
Date filed
1/9/2024, 08:21 PM
Previous filing
Nov 15, 2023
Next filing
Jan 25, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MIRM Common Stock Sale -$39.5K -1.41K -4.5% $28.03 29.9K Jan 8, 2024 Direct F1
holding MIRM Common Stock 75K Jan 8, 2024 By The Vig-Ancock Family Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units.